Related Experiment Video
Updated: Sep 26, 2025

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
Focused update: Guidelines of care for the management of actinic keratosis
Daniel B Eisen1, Robert P Dellavalle2, Lindsy Frazer-Green3
1Department of Dermatology, University of California, Davis, Sacramento, California.
Background:
Actinic keratoses (AKs) are rough scaly patches that arise on chronically UV-exposed skin and can progress to keratinocyte carcinoma.
Objective:
In 2021, the American Academy of Dermatology published guidelines to assist in clinical decision-making for the management of AK. The purpose of this focused guideline update is to incorporate recently available evidence on the use of topical tirbanibulin to treat AK.
Methods:
A multidisciplinary work group conducted a systematic review to evaluate data on the use of tirbanibulin for AK and applied the Grading of Recommendations, Assessment, Development, and Evaluation approach for assessing the certainty of the evidence and formulating and grading a clinical recommendation. The graded recommendation was voted on to achieve consensus.
Results:
Two trials were identified, and analysis of the evidence resulted in 1 recommendation.
Limitations:
This analysis is based on the best available evidence at the time it was conducted. Long-term efficacy and safety data are not currently available.
Conclusions:
A strong recommendation for the use of topical tirbanibulin to join the currently recommended list of topical therapies for AK was made on the basis of the available evidence.
Insights
Topical tirbanibulin is strongly recommended for treating actinic keratoses (AKs), a common skin condition caused by sun exposure. This guideline update incorporates new evidence for managing AKs effectively.
Area of Science:
- Dermatology
- Oncology
- Evidence-based medicine
Background:
- Actinic keratoses (AKs) are precancerous skin lesions resulting from chronic UV exposure.
- AKs can potentially progress to keratinocyte carcinoma, a type of skin cancer.
Purpose of the Study:
- To update clinical guidelines for managing AKs.
- To evaluate the efficacy and safety of topical tirbanibulin for AK treatment based on recent evidence.
Main Methods:
- A systematic review of available data on topical tirbanibulin for AK.
- Application of the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) approach.
- Multidisciplinary work group consensus through voting on the recommendation.
Main Results:
- Two clinical trials were identified and analyzed.
- A single, strong clinical recommendation was formulated based on the evidence.
Conclusions:
- Topical tirbanibulin is recommended as a treatment option for actinic keratoses.
- This recommendation is based on the best available evidence, though long-term data are pending.
Related Concept Videos
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Clinical Applications of Epidermal Stem Cells
Renewal of Skin Epidermal Stem Cells
Burn Injuries
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
Peripheral Artery Disease IV: Nursing Management
Hand hygiene
Hand washing...

